Abstract:Following the global-level Ebola virus disease (EVD) outbreak during 2014–2016, international collaboration with multiorganizational participation has rapidly increased. Given the greater priorities for research and development (R&D) outcomes despite the quantitative and qualitative lack of high-containment laboratory facilities in low- and middle-income countries (LMICs), where biological targets for investigation are located near their natural habitats, occupational readiness for health workers' safety has not been well-addressed, where limited global expert human resources are being deployed to high-containment laboratories including biosafety level 4 (BSL-4) facilities for case management and medical investigations. Pursuing scientific and managerial success to make laboratories efficient and productive, most laboratory safety policies have focused on the functionality of technical skills or performance, procedural methodologies, and supervision over the employees to collaborate in LMICs. The experts dispatched from advanced countries bring a long list of scientific tasks with high-tech devices, supplies, and training programs to introduce their collaboration with local partners in LMICs. However, the dispatched experts would subsequently realize their list becomes endless to establish their basic functions required in high-containment laboratories to ensure qualified scientific outcomes in LMICs. Under such circumstances where dual or multiple policies and standards accommodated pose dilemmas for operational procedures to ensure biosafety and biosecurity, all the frontline experts from both LMICs and advanced countries may be exposed to significant risks of life-threating infection of highly pathogenic agents like EVD, without any pragmatic measures or road maps to establish valued international collaboration, pursuing its sustainability. Given the fact mentioned above, we conducted a quick review of the key biosafety and biosecurity management documents, relevant policy analyses, and research to understand the current status and, if any, measures to dissolve critical dilemmas mentioned above. As a result, we found that occupational safety and health (OSH) aspects had not been sufficiently addressed, particularly in the context of international BSL-4 collaboration in LMICs. Moreover, consideration of OSH can be one of the key drivers to make such collaborative interventions more pragmatic, safer to reorient, harness disease-based vertical approaches, and harmonize policies of biosafety and biosecurity, particularly for collaborations organized in resource-limited settings.

Hypothalamic-pituitary-thyroid axis in moderate and intense exercise.

The Biosafety Research Road Map: The Search for Evidence to Support Practices in Human and Veterinary Laboratories

Global Foot-and-Mouth Disease Research Update and Gap Analysis: 5 - Biotherapeutics and Disinfectants

Foot-and-mouth disease virus: Prospects for using knowledge of virus biology to improve control of this continuing global threat

Single-carrier 61 Gbaud DP-16QAM transmission using bandwidth-limited DAC/ADC and narrow filtering equalization

Foot-and-Mouth Disease Virus: Immunobiology, Advances in Vaccines and Vaccination Strategies Addressing Vaccine Failures-An Indian Perspective

The Proposed Strategic Plan to Limit The Spread of Foot-and-Mouth Disease

Comparative studies on the anti‐punishment effects of chlordiazepoxide, buspirone and ritanserin in the pigeon, Geller‐Seifter and Vogel conflict procedures

Molecular epidemiology of foot-and-mouth disease (review)

We need a global framework for promoting safe handling of high consequence pathogens

Introduction and history of foot-and-mouth disease virus

The risk and mitigation of foot-and-mouth disease virus infection of pigs through consumption of contaminated feed

Natural and Vaccine Induced Immunity to FMD

Phenotypic plasticity of abdomen pigmentation in two geographic populations of Drosophila melanogaster: male–female comparison and sexual dimorphism

Virulence and Immune Evasion Strategies of FMDV: Implications for Vaccine Design

The Clinical Significance of Tumor Cell-Lined Vasculature in Ovarian Carcinoma: Implications for Anti-Vasculogenic Therapy

Advances in Reverse Genetics-Based Vaccines of Foot and Mouth Disease

Development of vaccines toward the global control and eradication of foot-and-mouth disease

Towards improvements in foot-and-mouth disease vaccine performance

Harmonization of Biosafety and Biosecurity Standards for High-Containment Facilities in Low- and Middle-Income Countries: An Approach From the Perspective of Occupational Safety and Health

Pathogenesis, biophysical stability and phenotypic variance of SAT2 foot-and-mouth disease virus